Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-012504
Filing Date
2022-05-05
Accepted
2022-05-05 12:19:50
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rdus-20220331.htm   iXBRL 10-Q 985498
2 EX-31.1 rdus03312210qex31d1.htm EX-31.1 13665
3 EX-31.2 rdus03312210qex31d2.htm EX-31.2 13667
4 EX-32.1 rdus03312210qex32d1.htm EX-32.1 11361
  Complete submission text file 0001628280-22-012504.txt   4961423

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rdus-20220331.xsd EX-101.SCH 38310
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rdus-20220331_cal.xml EX-101.CAL 50182
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rdus-20220331_def.xml EX-101.DEF 204938
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rdus-20220331_lab.xml EX-101.LAB 440834
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rdus-20220331_pre.xml EX-101.PRE 305558
52 EXTRACTED XBRL INSTANCE DOCUMENT rdus-20220331_htm.xml XML 685491
Mailing Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210
Business Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35726 | Film No.: 22895088
SIC: 2834 Pharmaceutical Preparations